Phytochemicals in the treatment of hyperpigmentation

References

• Halder RM, Nootheti PK. Ethnic skin disorders overview. J Am Acad Dermatol. 2003;48(6 Suppl):S143–148.
   Web of Science ®Google Scholar
• Woolery-Lloyd H, Kammer JN. Treatment of hyperpigmentation. Semin Cutan Med Surg. 2011;30(3):171–175.
   Web of Science ®Google Scholar
• Zhu W, Gao J. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. J Investig Dermatol Symp Proc. 2008;13(1):20–24.
   Google Scholar
• Draelos ZD. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther. 2007;20(5):308–313.
   PubMed Web of Science ®Google Scholar
• Sarkar R, Arora P, Garg KV. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther. 2013;6(1):4–11.
   Google Scholar
• Levin J, Momin SB. How much do we really know about our favorite cosmeceutical ingredients? J Clin Aesthet Dermatol. 2010;3(2):22–41.
   Google Scholar
• Bigby M. Snake oil for the 21st century. Arch Dermatol. 1998;134(12):1512–1514.
   Google Scholar
• Fisk WA, Agbai O, Lev-Tov HA, Sivamani RK. The use of botanically derived agents for hyperpigmentation: a systematic review. J Am Acad Dermatol. 2014;70(2):352–365.
   PubMed Web of Science ®Google Scholar
• Chahal DS, Sivamani RK, Isseroff RR, Dasu MR. Plant-based modulation of Toll-like receptors: an emerging therapeutic model. Phytother Res. 2013;27(10):1423–1438.
   Web of Science ®Google Scholar
• Fisk WA, Lev-Tov HA, Sivamani RK. Botanical and phytochemical therapy of acne: a systematic review. Phytother Res. 2014;28(8):1137–1152.
   Web of Science ®Google Scholar
• Leo MS, Sivamani RK. Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease. Arch Dermatol Res. 2014;306(10):861–871.
   PubMed Web of Science ®Google Scholar
• Sivamani RK, Ma BR, Wehrli LN, Maverakis E. Phytochemicals and naturally derived substances for wound healing. Adv Wound Care (New Rochelle). 2012;1(5):213–217.
   Google Scholar
• Jones K, Hughes J, Hong M, Jia Q, Orndorff S. Modulation of melanogenesis by aloesin: a competitive inhibitor of tyrosinase. Pigment Cell Res. 2002;15(5):335–340.
   PubMedGoogle Scholar
• Yagi A, Kanbara T, Morinobu N. Inhibition of mushroom-tyrosinase by aloe extract. Planta Med. 1987;53(6):515–517.
   Web of Science ®Google Scholar
• Choi S, Lee SK, Kim JE, Chung MH, Park YI. Aloesin inhibits hyperpigmentation induced by UV radiation. Clin Exp Dermatol. 2002;27(6):513–515.
   PubMed Web of Science ®Google Scholar
• Lee J, Jun H, Jung E, Ha J, Park D. Whitening effect of alpha-bisabolol in Asian women subjects. Int J Cosmet Sci. 2010;32(4):299–303.
   PubMedGoogle Scholar
• Kim S, Lee J, Jung E, et al. Mechanisms of depigmentation by alpha-bisabolol. J Dermatol Sci. 2008;52(3):219–222.
   Web of Science ®Google Scholar
• Hori I, Nihei K, Kubo I. Structural criteria for depigmenting mechanism of arbutin. Phytother Res. 2004;18(6):475–479.
   Web of Science ®Google Scholar
• Maeda K, Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther. 1996;276(2):765–769.
   Web of Science ®Google Scholar
• Boissy RE, Visscher M, DeLong MA. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Exp Dermatol. 2005;14(8):601–608.
   Web of Science ®Google Scholar
• Ertam I, Mutlu B, Unal I, Alper S, Kivcak B, Ozer O. Efficiency of ellagic acid and arbutin in melasma: a randomized, prospective, open-label study. J Dermatol. 2008;35(9):570–574.
   PubMed Web of Science ®Google Scholar
• Shimogaki H, Tanaka Y, Tamai H, Masuda M. In vitro and in vivo evaluation of ellagic acid on melanogenesis inhibition. Int J Cosmet Sci. 2000;22(4):291–303.
   Google Scholar
• Kasai K, Yoshimura M, Koga T, Arii M, Kawasaki S. Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin. J Nutr Sci Vitaminol (Tokyo). 2006;52(5):383–388.
   Web of Science ®Google Scholar
• Yokota T, Nishio H, Kubota Y, Mizoguchi M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res. 1998;11(6):355–361.
   PubMedGoogle Scholar
• Proteggente AR, Basu-Modak S, Kuhnle G, et al. Hesperetin glucuronide, a photoprotective agent arising from flavonoid metabolism in human skin fibroblasts. Photochem Photobiol. 2003;78(3):256–261.
   Web of Science ®Google Scholar
• Huang YB, Lee KF, Huang CT, Tsai YH, Wu PC. The effect of component of cream for topical delivery of hesperetin. Chem Pharm Bull (Tokyo). 2010;58(5):611–614.
   Web of Science ®Google Scholar
• Usach I, Talens-Visconti R, Magraner-Pardo L, Peris JE. Hesperetin induces melanin production in adult human epidermal melanocytes. Food Chem Toxicol. 2015;80:80–84.
   Web of Science ®Google Scholar
• Zubair S, Mujtaba G. Comparison of efficacy of topical 2% liquiritin, topical 4% liquiritin and topical 4% hydroquinone in the management of melasma. JPAD. 2009;19:158–163.
   Google Scholar
• Amer M, Metwalli M. Topical liquiritin improves melasma. Int J Dermatol. 2000;39(4):299–301.
   PubMed Web of Science ®Google Scholar
• Handog EB, Galang DA, de Leon-Godinez MA, Chan GP. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women. Int J Dermatol. 2009;48(8):896–901.
   PubMed Web of Science ®Google Scholar
• Provinciali M, Papalini F, Orlando F, et al. Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice. Cancer Res. 2007;67(5):2022–2029.
   Web of Science ®Google Scholar
• Kren V, Walterova D. Silybin and silymarin – new effects and applications. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005;149(1):29–41.
   PubMedGoogle Scholar
• Choo SJ, Ryoo IJ, Kim YH, et al. Silymarin inhibits melanin synthesis in melanocyte cells. J Pharm Pharmacol. 2009;61(5):663–667.
   Web of Science ®Google Scholar
• Altaei T. The treatment of melasma by silymarin cream. BMC Dermatol. 2012;12:18.
   PubMedGoogle Scholar
• Costa A, Moises TA, Cordero T, Alves CR, Marmirori J. Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma. An Bras Dermatol. 2010;85(5):613–620.
   PubMed Web of Science ®Google Scholar
• Reuter J, Merfort I, Schempp CM. Botanicals in dermatology: an evidence-based review. Am J Clin Dermatol. 2010;11(4):247–267.
   PubMed Web of Science ®Google Scholar
• Kokcam I. Toxic epidermal necrolysis probably due to cosmetic cream: a case report. Acta Dermatovenerol Alp Pannonica Adriat. 2009;18(1):39–42.
   Google Scholar
• Thornfeldt C. Cosmeceuticals containing herbs: fact, fiction, and future. Dermatol Surg. 2005;31(7 Pt 2):873–880; discussion 880.
   Web of Science ®Google Scholar
• Keane FM, Munn SE, du Vivier AW, Taylor NF, Higgins EM. Analysis of Chinese herbal creams prescribed for dermatological conditions. BMJ. 1999;318(7183):563–564.
   Google Scholar
• Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol. 1997;37(4):344–350.
   PubMed Web of Science ®Google Scholar